| Application no. and date | 11166787.9 (espacenet) (Federated) (European Patent Register), 20061102 | | Patent/reg. no. and date | DK/EP 2380592, 20180307 | | Publication date | 20111026 | | Priority no. and date | US 736623 P, 20051114 | | EP pub. no. and date |
EP 2380592 20111026 | | Effective date | | | Applicant/owner | Teva Pharmaceuticals
International GmbH, Schlüsselstrasse 12
8645 Jona, CH | | Applicant ref. no. | P63988DK01 | | Inventor | ROSENTHAL, Arnon, 150 Normandy Lane
Woodside, CA 94062, US,
Zeller, Joerg, Rinat Neuroscience Corp.
230 East Grand Avenue
South San Francisco, CA 94080, US,
Poulsen, Kristian, Todd, Rinat Neuroscience, Corp.
230 East Grand Avenue
South San Francisco, CA 94080, US,
Abdiche, Yasmina, Noubia, Rinat Neuroscience Corp.
230 East Grand Avenue
South San Francisco, CA 94080, US,
Pons, Jaume, Rinat Neuroscience, Corp.
230 East Grand Avenue
South San Francisco, CA 94080, US,
Collier, Sierra, Jones, Rinat Neuroscience, Corp.
230 East Grand Avenue
South San Francisco, CA 94080, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 5/24 (2006.01) , C07K 16/26 (2006.01) | | Title | Antagonistantistof rettet mod calcitonin gen-relateret peptid | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2019 00036 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
